Advancing Decentralized Trials Using An mHealth Platform

While COVID-19 has ushered in some much-needed innovations in terms of technology solutions to power decentralized, not all solutions are created equal. When evaluating mHealth technology, for example, the integrity of data collection and data privacy are paramount. Join Datacubed Health experts Michael Crumsho and Mike Bassick for a discussion on the key considerations when making an investment in an mHealth platform. In this webinar, we’ll discuss:

• The impact that COVID-19 has had on accelerating the shift to decentralized trials
• Why your organization should consider an mHealth platform
• The key criteria that should be evaluated for your solution, including capabilities to enhance the patient experience, testing and release processes that do not disrupt any current studies, and security and support procedures